ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,117Medicare Part D Prescriptions Filled, Including Refills

Rank: 402 out of 3001

$1.02M Total Retail Price of All Prescriptions

Rank: 101 out of 3001

446 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
10% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 446 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

11% of this provider’s 446 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

3% of this provider’s 9,202 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

33% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$101 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
SIMVASTATIN 355 303 1 1
FUROSEMIDE 281 268 2 6
METOPROLOL SUCCINATE 279 267 3 19
ATORVASTATIN CALCIUM 267 239 4 11
LISINOPRIL 236 190 5 2
CLOPIDOGREL 208 197 6 28
LEVOTHYROXINE SODIUM 207 202 7 3
AMLODIPINE BESYLATE 195 190 8 5
NEXIUM 169 159 9 23
WARFARIN SODIUM 168 168 10 12
HYDROCODONE-ACETAMINOPHEN 159 103 S3 11 7
METOPROLOL TARTRATE 153 132 12 8
PLAVIX 151 143 13 46
CRESTOR 146 137 14 33
PANTOPRAZOLE SODIUM 143 131 15 43
OMEPRAZOLE 139 123 16 4
LISINOPRIL-HYDROCHLOROTHIAZIDE 135 101 17 22
LOSARTAN POTASSIUM 132 131 18 21
SYNTHROID 130 130 19 71
ATENOLOL 126 93 20 18
CLONIDINE HCL 120 105 21 64
AZITHROMYCIN 115 101 22 36
METFORMIN HCL 108 101 23 9
TAMSULOSIN HCL 104 102 24 29
SERTRALINE HCL 101 88 25 20
LEVOFLOXACIN 87 78 26 115
CARVEDILOL 82 80 27 25
DIGOXIN 82 82 27 65
ALLOPURINOL 82 81 27 35
LOSARTAN-HYDROCHLOROTHIAZIDE 82 79 27 49
OXYCODONE-ACETAMINOPHEN 78 78 S2 31 32
RAMIPRIL 71 71 32 114
CELEBREX 69 69 33 89
DILTIAZEM 24HR ER 66 59 34 131
GABAPENTIN 62 58 35 14
GLYBURIDE-METFORMIN HCL 62 57 R 35 196
METHYLPREDNISOLONE 61 58 37 121
AMLODIPINE-ATORVASTATIN 58 58 38 463
ZOLPIDEM TARTRATE 57 46 39 24
SPIRIVA 53 53 40 57
DIOVAN 53 53 40 50
SINGULAIR 52 51 42 95
LIPITOR 51 49 43 100
GLYBURIDE 51 51 R 43 62
KLOR-CON M20 51 50 43 52
PRAVASTATIN SODIUM 51 39 43 13
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 29, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.